AstraZeneca sues Mylan after securing fresh delivery patent on Symbicort

AstraZeneca has opened another front in its effort to protect its respiratory disease drug Symbicort from generic competition, securing a patent and immediately following up with a lawsuit against Mylan and Kindeva Drug Delivery.